About us
Who we are
Governance
Staff
Vacancies
What we do
Members
EuropaBio Members
About Membership
How we work
Healthcare Biotechnology Council
Cell & Gene Therapies
Medicines For Rare Diseases And Children
Regulatory Efficiency
Biosimilars & Public Procurement
Data & Digital
Patient Bio-Forum
Industrial Biotechnology Council
Food, Feed & Nutrition
Circular Bioeconomy
National Associations Council
SME Platform
Biomanufacturing Platform
Activities
25 Years of Innovation
EFIB 2022
European Biotech Week
Events
Newsroom
News & Publications
Newsletter
Library
Become a member
✕
23/05/2023
23/05/2023
EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation
10/05/2023
10/05/2023
#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee
10/05/2023
10/05/2023
Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski
25/04/2022
25/04/2022
Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare
08/09/2021
08/09/2021
Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies
20/07/2021
20/07/2021
EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare
12/02/2021
12/02/2021
EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare
EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases.
Become a member